Tower Research Capital LLC (Trc) Bria Cell Therapeutics Corp. Transaction History

Tower Research Capital LLC (Trc)

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$5.72 - $7.58 $16,004 - $21,208	-2,798 Reduced 66.83%	1,389 $8,000
Q1 2023 May 09, 2023	BUY	$4.59 - $7.99 $2,877 - $5,009	627 Added 17.61%	4,187 $31,000
Q4 2022 Feb 10, 2023	BUY	$4.28 - $6.73 $5,859 - $9,213	1,369 Added 62.48%	3,560 $16,000
Q3 2022 Nov 10, 2022	SELL	$3.0 - $8.31 $3,204 - $8,875	-1,068 Reduced 32.77%	2,191 $13,000
Q2 2022 Aug 15, 2022	SELL	$4.28 - $11.9 $629 - $1,749	-147 Reduced 4.32%	3,259 $18,000
Q1 2022 May 12, 2022	SELL	$5.91 - $10.14 $6,731 - $11,549	-1,139 Reduced 25.06%	3,406 $35,000
Q4 2021 Feb 14, 2022	BUY	$7.1 - $10.61 $4,558 - $6,811	642 Added 16.45%	4,545 $38,000
Q3 2021 Nov 15, 2021	BUY	$4.4 - $9.28 $2,706 - $5,707	615 Added 18.7%	3,903 $31,000
Q2 2021 Aug 16, 2021	BUY	$2.89 - $6.57 $9,502 - $21,602	3,288 New	3,288 $18,000

Ticker BCTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,518,000
Market Cap $14.9M
Description
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.